ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 91 filers reported holding ENDOCYTE INC in Q1 2018. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $96,000 | +113.3% | 10,600 | 0.0% | 0.01% | +160.0% |
| Q4 2017 | $45,000 | -19.6% | 10,600 | -51.6% | 0.01% | -37.5% |
| Q1 2017 | $56,000 | -12.5% | 21,884 | -13.4% | 0.01% | -11.1% |
| Q4 2016 | $64,000 | -25.6% | 25,284 | -8.9% | 0.01% | -30.8% |
| Q3 2016 | $86,000 | -11.3% | 27,743 | -8.6% | 0.01% | -18.8% |
| Q2 2016 | $97,000 | +3.2% | 30,338 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $94,000 | -23.0% | 30,338 | 0.0% | 0.02% | -27.3% |
| Q4 2015 | $122,000 | -43.0% | 30,338 | -35.1% | 0.02% | -48.8% |
| Q3 2015 | $214,000 | -17.7% | 46,728 | -6.7% | 0.04% | -10.4% |
| Q2 2015 | $260,000 | -10.0% | 50,110 | +8.7% | 0.05% | -2.0% |
| Q1 2015 | $289,000 | -10.0% | 46,090 | -9.7% | 0.05% | 0.0% |
| Q4 2014 | $321,000 | -13.9% | 51,040 | -16.8% | 0.05% | -15.5% |
| Q3 2014 | $373,000 | +39.7% | 61,326 | +51.3% | 0.06% | +34.9% |
| Q2 2014 | $267,000 | -60.9% | 40,536 | +41.5% | 0.04% | -64.2% |
| Q1 2014 | $682,000 | – | 28,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 30,639 | $95,000 | 0.10% |
| Leisure Capital Management | 29,655 | $92,000 | 0.09% |
| Cribstone Capital Management, LLC | 32,541 | $101,000 | 0.08% |
| HIGHLAND CAPITAL MANAGEMENT LP | 442,656 | $1,372,000 | 0.06% |
| PINNACLE ASSOCIATES LTD | 898,096 | $2,784,000 | 0.06% |
| Bellevue Group AG | 100,000 | $310,000 | 0.06% |
| Baker Brothers Advisors | 1,695,865 | $5,257,000 | 0.06% |
| Curi RMB Capital, LLC | 217,885 | $675,000 | 0.04% |
| Spark Investment Management LLC | 116,300 | $360,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 244,192 | $757,000 | 0.02% |